Keywords
Last Name
Institution

RAJAT J KUDCHADKER

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Physics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016 May-Jun; 15(3):274-82. PMID: 26916105.
      View in: PubMed
    2. Du W, Johnson JL, Jiang W, Kudchadker RJ. On the selection of gantry and collimator angles for isocenter localization using Winston-Lutz tests. J Appl Clin Med Phys. 2016; 17(1):5792. PMID: 26894350.
      View in: PubMed
    3. Yu ZH, Kudchadker R, Dong L, Zhang Y, Court LE, Mourtada F, Yock A, Tucker SL, Yang J. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. J Appl Clin Med Phys. 2016; 17(1):5888. PMID: 26894362.
      View in: PubMed
    4. Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. J Appl Clin Med Phys. 2015; 16(5):5057. PMID: 26699290.
      View in: PubMed
    5. Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil. Brachytherapy. 2015 Mar-Apr; 14(2):160-5. PMID: 25255712.
      View in: PubMed
    6. Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ. Establishing high-quality prostate brachytherapy using a phantom simulator training program. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):579-86. PMID: 25151539.
      View in: PubMed
    7. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy. Med Phys. 2014 Aug; 41(8):081708. PMID: 25086518.
      View in: PubMed
    8. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models. Med Phys. 2014 May; 41(5):051705. PMID: 24784371.
      View in: PubMed
    9. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol. 2014 May 21; 59(10):2505-16. PMID: 24778352; PMCID: PMC4090919.
    10. Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e239-46. PMID: 25407875.
      View in: PubMed
    11. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys. 2014 Apr 1; 88(5):1074-84. PMID: 24661661.
      View in: PubMed
    12. Gossman MS, Hancock SS, Kudchadker RJ, Lundahl PR, Cao M, Melhus CS. Brachytherapy dose-volume histogram commissioning with multiple planning systems. J Appl Clin Med Phys. 2014; 15(2):4620. PMID: 24710449.
      View in: PubMed
    13. Du W, Cho SH, Zhang X, Hoffman KE, Kudchadker RJ. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans. Med Phys. 2014 Feb; 41(2):021716. PMID: 24506607.
      View in: PubMed
    14. Wootton L, Kudchadker R, Lee A, Beddar S. Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer. Phys Med Biol. 2014 Feb 7; 59(3):647-60. PMID: 24434775; PMCID: PMC3965908.
    15. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis. 2013 Dec; 16(4):346-51. PMID: 23939133.
      View in: PubMed
    16. Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Aug 1; 86(5):835-41. PMID: 23726001.
      View in: PubMed
    17. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):68-74. PMID: 23669149.
      View in: PubMed
    18. Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys. 2013 May; 40(5):051714. PMID: 23635262; PMCID: PMC3651206.
    19. Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Med Dosim. 2013; 38(3):251-4. PMID: 23540491.
      View in: PubMed
    20. Register SP, Kudchadker RJ, Levy LB, Swanson DA, Pugh TJ, Bruno TL, Frank SJ. An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial. Brachytherapy. 2013 May-Jun; 12(3):210-6. PMID: 23466360; PMCID: PMC3891368.
    21. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, van Vulpen M, Frank SJ. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy. 2013 Sep-Oct; 12(5):401-7. PMID: 23380383.
      View in: PubMed
    22. Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker SL, Kuban D, Dong L. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Pract Radiat Oncol. 2013 Oct-Dec; 3(4):329-36. PMID: 24674406.
      View in: PubMed
    23. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):e39-46. PMID: 23102837; PMCID: PMC3840533.
    24. Wootton LS, Kudchadker RJ, Beddar AS, Lee AK. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. J Appl Clin Med Phys. 2012; 13(5):3945. PMID: 22955660.
      View in: PubMed
    25. Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1169-78. PMID: 22704703; PMCID: PMC3805837.
    26. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy. 2013 Jan-Feb; 12(1):30-7. PMID: 22727474.
      View in: PubMed
    27. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy. Brachytherapy. 2013 May-Jun; 12(3):204-9. PMID: 22673704; PMCID: PMC4158734.
    28. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim. 2012; 37(4):387-90. PMID: 22560295; PMCID: PMC3935513.
    29. Du W, Gao S, Wang X, Kudchadker RJ. Quantifying the gantry sag on linear accelerators and introducing an MLC-based compensation strategy. Med Phys. 2012 Apr; 39(4):2156-62. PMID: 22482636.
      View in: PubMed
    30. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e765-71. PMID: 22300559; PMCID: PMC3891366.
    31. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):e7-e13. PMID: 24674130.
      View in: PubMed
    32. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ. Long-term tumor control after brachytherapy for base-of-prostate cancer. J Contemp Brachytherapy. 2011 Dec; 3(4):183-7. PMID: 23346126; PMCID: PMC3551361.
    33. Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: a case report. Med Dosim. 2012; 37(2):208-13. PMID: 21978532.
      View in: PubMed
    34. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med. 2012 Jul; 28(3):240-4. PMID: 21875820.
      View in: PubMed
    35. Huang JY, Newhauser WD, Zhu XR, Lee AK, Kudchadker RJ. Investigation of dose perturbations and the radiographic visibility of potential fiducials for proton radiation therapy of the prostate. Phys Med Biol. 2011 Aug 21; 56(16):5287-302. PMID: 21799236.
      View in: PubMed
    36. Li H, Lee AK, Johnson JL, Zhu RX, Kudchadker RJ. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. J Appl Clin Med Phys. 2011; 12(3):3471. PMID: 21844859.
      View in: PubMed
    37. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy. 2011 Sep-Oct; 10(5):401-8. PMID: 21306959.
      View in: PubMed
    38. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Brachytherapy. 2011 Jul-Aug; 10(4):269-74. PMID: 21296031.
      View in: PubMed
    39. Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys. 2011 Jan; 38(1):34-9. PMID: 21361172.
      View in: PubMed
    40. Sha RL, Reddy PY, Rao R, Muralidhar KR, Kudchadker RJ. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma. Med Dosim. 2011; 36(4):377-82. PMID: 21144733.
      View in: PubMed
    41. Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol. 2010 Dec 7; 55(23):7135-47. PMID: 21076190.
      View in: PubMed
    42. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim. 2011; 36(2):200-5. PMID: 20537886.
      View in: PubMed
    43. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy. Am J Clin Oncol. 2010 Apr; 33(2):173-5. PMID: 20010077.
      View in: PubMed
    44. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology. 2009 Sep; 74(3):601-5. PMID: 19589580.
      View in: PubMed
    45. Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1283-9. PMID: 19427750.
      View in: PubMed
    46. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management. Cancer. 2009 May 1; 115(9):1827-39. PMID: 19248043.
      View in: PubMed
    47. Brooks C, Cheung RM, Kudchadker RJ. Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study. Med Dosim. 2010; 35(2):87-91. PMID: 19931019.
      View in: PubMed
    48. Zullo JR, Kudchadker RJ, Zhu XR, Sahoo N, Gillin MT. LiF TLD-100 as a dosimeter in high energy proton beam therapy--can it yield accurate results? Med Dosim. 2010; 35(1):63-6. PMID: 19931017.
      View in: PubMed
    49. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol. 2009 Apr; 181(4):1658-63; discussion 1663-4. PMID: 19233434.
      View in: PubMed
    50. Weinberg R, Antolak JA, Starkschall G, Kudchadker RJ, White RA, Hogstrom KR. Influence of source parameters on large-field electron beam profiles calculated using Monte Carlo methods. Phys Med Biol. 2009 Jan 7; 54(1):105-16. PMID: 19075360.
      View in: PubMed
    51. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK. Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans. Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):40-8. PMID: 19058919.
      View in: PubMed
    52. Nelson C, Balter P, Morice RC, Choi B, Kudchadker RJ, Bucci K, Chang JY, Dong L, Tucker S, Vedam S, Briere T, Starkschall G. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. J Appl Clin Med Phys. 2008; 9(4):2766. PMID: 19020478.
      View in: PubMed
    53. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1):274-80. PMID: 18406891.
      View in: PubMed
    54. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1):5-8. PMID: 18406882.
      View in: PubMed
    55. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int J Radiat Oncol Biol Phys. 2008 Oct 1; 72(2):623-7. PMID: 18410998.
      View in: PubMed
    56. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71(3):813-20. PMID: 18207664.
      View in: PubMed
    57. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol. 2007 Nov; 85(2):251-9. PMID: 17892900.
      View in: PubMed
    58. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Aug 1; 68(5):1529-36. PMID: 17544595.
      View in: PubMed
    59. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1059-65. PMID: 17241755; PMCID: PMC2081969.
    60. Zullo JR, Kudchadker R, Wu R, Lee A, Prado K. Implication of CT table sag on geometrical accuracy during virtual simulation. Med Dosim. 2007; 32(4):233-6. PMID: 17980822.
      View in: PubMed
    61. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Nov 1; 66(3):883-91. PMID: 17011461.
      View in: PubMed
    62. Kudchadker RJ, Chang EL, Bryan F, Maor MH, Famiglietti R. An evaluation of radiation exposure from portal films taken during definitive course of pediatric radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1229-35. PMID: 15234060.
      View in: PubMed
    63. Zullo JR, Bloch C, Chi PC, Kudchadker R. Linearity and uniformity response as an indicator of performance for Agfa ADC-MD10 computed radiography plates. Med Dosim. 2004; 29(2):118-21. PMID: 15191759.
      View in: PubMed
    64. Kirsner SM, Kudchadker RJ, Prado KL, Ha CS, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):1135-42. PMID: 12605993.
      View in: PubMed
    65. Prado KL, Kirsner SM, Kudchadker RJ, Steadham RE, Lane RG. Enhanced dynamic wedge factors at off-axis points in asymmetric fields. J Appl Clin Med Phys. 2003; 4(1):75-84. PMID: 12540821.
      View in: PubMed
    66. Kudchadker RJ, Antolak JA, Morrison WH, Wong PF, Hogstrom KR. Utilization of custom electron bolus in head and neck radiotherapy. J Appl Clin Med Phys. 2003; 4(4):321-33. PMID: 14604422.
      View in: PubMed
    67. Kudchadker RJ, Hogstrom KR, Garden AS, McNeese MD, Boyd RA, Antolak JA. Electron conformal radiotherapy using bolus and intensity modulation. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):1023-37. PMID: 12095572.
      View in: PubMed
    68. Lee CL, Zhou XL, Kudchadker RJ, Harmon F, Harker YD. A Monte Carlo dosimetry-based evaluation of the 7Li(p,n)7Be reaction near threshold for accelerator boron neutron capture therapy. Med Phys. 2000 Jan; 27(1):192-202. PMID: 10659757.
      View in: PubMed
    69. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. Journal of Applied Clinical Medical Physics. 17:442-455.
    70. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. Journal of Applied Clinical Medical Physics. 16:62-75.
    71. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy.
    72. In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiation Measurements. 47:921-929.
    73. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer. American Journal of Clinical Oncology: Cancer Clinical Trials.
    74. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients. Journal of Contemporary Brachytherapy. 8:233-240.
    75. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy.
    76. Brachytherapy dose-volume histogram commissioning with multiple planning systems. Journal of Applied Clinical Medical Physics. 15:110-120.
    77. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. Journal of Applied Clinical Medical Physics. 9:110-122.
    78. Erratum. International Journal of Radiation Oncology Biology Physics. 60:350.
    79. On the selection of gantry and collimator angles for isocenter localization using Winston-Lutz tests. Journal of Applied Clinical Medical Physics. 17:167-178.
    80. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Practical Radiation Oncology. 2.
    81. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. Journal of Applied Clinical Medical Physics. 13:190-197.
    82. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. Journal of Applied Clinical Medical Physics. 17:246-258.
    83. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Practical Radiation Oncology. 3:329-336.
    84. Thermal neutron flux mapping in a head phantom. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 422:106-110.
    85. Multileaf collimation for electron intensity modulation. 210-213.
    86. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment. Medical Physics. 43:4312-4322.
    87. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. Journal of Applied Clinical Medical Physics. 12:23-31.
    KUDCHADKER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description